Expand Content

Philip Bailin, MD, MBA


Philip Bailin, MD, MBA
Department: Dermatology
Retired Staff
Location: Cleveland Clinic Main Campus
Mail Code A61
9500 Euclid Avenue
Cleveland, OH 44195
Type of Doctor:
Adults Only

Biographical Sketch

Philip L. Bailin, MD, M.B.A., F.A.C.P., is immediate past Chairman of the Department of Dermatology (1977- 2005) at Cleveland Clinic. After receiving his medical degree from Northwestern University Medical School in Chicago, Dr. Bailin completed his internship and residency in Dermatology at Cleveland Clinic. He completed a fellowship in Dermatopathology at the Armed Forces Institute of Pathology in Washington D.C., as well as a fellowship in MOHS micrographic surgery at the University of Wisconsin in Madison, WI.

His special interests include laser surgery, cosmetic surgery, cosmetic injectable fillers and facial treatments.

His clinical interests include cosmetic surgery, Mohs micrographic surgery, laser surgery and cutaneous oncology. Dr. Bailin has been listed in “Best Doctors in America” numerous times.

Board-certified in Dermatology and Laser Surgery, Dr. Bailin is a Fellow of the American Academy of Dermatology and the American College of Physicians. He is past president and an active member of the American College of Mohs Surgery, the Association of Academic Dermatologic Surgeons and the American Society for Dermatologic Surgery.

In addition, Dr. Bailin has served on many professional societies, including the American Academy of Dermatology, the Skin Cancer Foundation and the International Society for Dermatologic Surgery. A frequent national and international lecturer at professional meetings, Dr. Bailin has published more than 120 articles and book chapters on the diagnosis and management of skin cancer, laser treatment of skin diseases, facial rejuvenation techniques and cutaneous surgical techniques. Currently, Dr. Bailin's primary research interest is in applications and mechanisms of photodynamic therapy of skin cancer and pre-cancer.

Dr. Bailin also received his M.B.A. from the Weatherhead School of Management at Case Western Reserve University. He has served as Cleveland Clinic's Director of the Office of Practice Management and as Associate Director of Leadership Development in the Office of Professional Staff Affairs.

Professional Highlights

  • Past-President: American Society for Dermatological Surgery
  • Past-President: American College of MOHS Surgery
  • Past-President: Association of Academic Dermatologic Surgeons

Education & Fellowships

Graduate - Case Western Reserve University
Cleveland, OH USA
Fellowship - University of Wisconsin Hospital and Clinic
Madison, WI USA
Fellowship - Armed Forces Institute of Pathology
Washington, DC USA
Residency - Cleveland Clinic
Cleveland, OH USA
Internship - Cleveland Clinic
Mixed Medicine
Cleveland, OH USA
Medical School - Northwestern University Feinberg School of Medicine
Chicago, IL USA
Undergraduate - Northwestern University
Chicago, IL USA


  • Dermatology

Specialty Interests

Cutaneous oncology, laser surgery, Mohs Micrographic Surgery, malignant melanoma, cosmetic Surgery

Awards & Honors

Named to Best Doctors in America for Dermatology and Cancer Specialists and multiple years by Castle-Connelly survey, Cleveland Magazine and Northern Ohio Live.

Additional Training

  • Executive MBA:Weatherhead School of Management, Case Western Reserve University

Innovations & Patents

  • Introduced MOHS (microscopically controlled) surgery for skin cancer removal to Northeast Ohio. This method has the highest cure rate of any available modality.
  • Pioneered the use of lasers nationally and internationally for treatment of malignant and benign skin diseases and for aesthetic rejuvenation.
  • Introduced the use of biologic filler substances in Ohio for aesthetic and reconstructive purposes.


  • Fellow:American Academy of Dermatology
  • Fellow: American College of MOHS Surgery
  • Fellow: American College of Physicians
  • Fellow:American Dermatological Association
  • Fellow: American Society for Dermatologic Surgery

Treatment & Services

Specialty in Diseases and Conditions

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 1/2/2014, Dr. Bailin has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English